CDH2 and breast cancer: The expression levels of N-cadherin, CK18, and CK19 in PMNs were higher in breast cancer patients than in HVs (p = 0.004, p = 0.003, and p = 0.003, respectively); however, in MCs, there was no statistical difference in expression levels between breast cancer patients and HVs.